Trading Report: Today: Commerce Bank Reached $10,202,000 position of UnitedHealth Group Inc. (UNH)

Today: Commerce Bank Reached $10,202,000 position  of UnitedHealth Group Inc. (UNH)

Commerce Bank raised its position in shares of UnitedHealth Group Inc. (NYSE:UNH) by 0.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 72,873 shares of the healthcare conglomerate’s stock after buying an additional 277 shares during the period. Commerce Bank’s holdings in UnitedHealth Group were worth $10,202,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the stock. Gateway Investment Advisers LLC boosted its stake in shares of UnitedHealth Group by 8.8% in the second quarter. Gateway Investment Advisers LLC now owns 815,807 shares of the healthcare conglomerate’s stock worth $115,192,000 after buying an additional 66,274 shares in the last quarter. Ballentine Partners LLC raised its position in UnitedHealth Group by 7.6% in the third quarter. Ballentine Partners LLC now owns 6,074 shares of the healthcare conglomerate’s stock worth $850,000 after buying an additional 430 shares during the last quarter. AGF Investments Inc. raised its position in UnitedHealth Group by 377.8% in the second quarter. AGF Investments Inc. now owns 423,387 shares of the healthcare conglomerate’s stock worth $59,771,000 after buying an additional 334,776 shares during the last quarter. British Airways Pensions Investment Management Ltd raised its position in UnitedHealth Group by 15.2% in the second quarter. British Airways Pensions Investment Management Ltd now owns 390,988 shares of the healthcare conglomerate’s stock worth $55,426,000 after buying an additional 51,460 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in UnitedHealth Group by 0.6% in the second quarter. Robeco Institutional Asset Management B.V. now owns 438,040 shares of the healthcare conglomerate’s stock worth $61,853,000 after buying an additional 2,743 shares during the last quarter. 84.92% of the stock is owned by institutional investors and hedge funds.

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% on Monday, reaching $152.11. 4,990,944 shares of the company’s stock traded hands. The firm’s 50 day moving average is $143.37 and its 200 day moving average is $139.61. The firm has a market capitalization of $144.61 billion, a P/E ratio of 25.31 and a beta of 0.63. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.09. The firm had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.09 billion. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The company’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.77 EPS. Analysts expect that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Investors of record on Friday, December 2nd will be issued a $0.625 dividend. The ex-dividend date is Wednesday, November 30th. This represents a $2.50 annualized dividend and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.93%.

A number of research firms have weighed in on UNH. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, November 23rd. Mizuho lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating in a research report on Wednesday, November 9th. Credit Suisse Group AG reiterated an “outperform” rating and issued a $160.00 price target (up from $155.00) on shares of UnitedHealth Group in a research report on Friday, October 21st. Vetr lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $144.66 price target for the company. in a research report on Tuesday, October 18th. Finally, Jefferies Group reiterated a “buy” rating and issued a $163.00 price target on shares of UnitedHealth Group in a research report on Sunday, October 16th. Two investment analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $158.03.

In related news, Director Kenneth Irwin Shine sold 325 shares of the business’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.99, for a total value of $47,121.75. Following the sale, the director now directly owns 28,613 shares in the company, valued at approximately $4,148,598.87. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 40,000 shares of the business’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares in the company, valued at $271,100,350.50. The disclosure for this sale can be found here. 1.65% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Related posts

Leave a Comment